Total Wealth Planning & Management Inc. Takes Position in Kenvue Inc. $KVUE

Key Points

• Total Wealth Planning & Management Inc. invested approximately $698,000 in 33,364 shares of Kenvue Inc. during the second quarter.
• Kenvue has announced an increase in its quarterly dividend to $0.2075 per share, reflecting an annualized dividend yield of 4.9%.
• Despite reporting a slight decline in revenue during its recent quarterly earnings, Kenvue exceeded earnings estimates with $0.29 per share compared to the consensus of $0.28.

Total Wealth Planning & Management Inc. purchased a new stake in shares of Kenvue Inc. (NYSE:KVUE - Free Report) during the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund purchased 33,364 shares of the company's stock, valued at approximately $698,000.

A number of other institutional investors and hedge funds have also modified their holdings of the business. Vanguard Group Inc. grew its holdings in shares of Kenvue by 4.9% during the first quarter. Vanguard Group Inc. now owns 229,144,387 shares of the company's stock valued at $5,494,882,000 after buying an additional 10,600,682 shares in the last quarter. Charles Schwab Investment Management Inc. grew its holdings in shares of Kenvue by 2.5% during the first quarter. Charles Schwab Investment Management Inc. now owns 25,606,238 shares of the company's stock valued at $613,882,000 after buying an additional 633,461 shares in the last quarter. Boston Partners grew its holdings in shares of Kenvue by 7.4% during the first quarter. Boston Partners now owns 25,346,453 shares of the company's stock valued at $606,920,000 after buying an additional 1,750,490 shares in the last quarter. JPMorgan Chase & Co. grew its holdings in shares of Kenvue by 11.6% during the first quarter. JPMorgan Chase & Co. now owns 24,912,226 shares of the company's stock valued at $597,395,000 after buying an additional 2,597,920 shares in the last quarter. Finally, American Century Companies Inc. grew its holdings in shares of Kenvue by 15.7% during the first quarter. American Century Companies Inc. now owns 21,828,854 shares of the company's stock valued at $523,456,000 after buying an additional 2,961,716 shares in the last quarter. Hedge funds and other institutional investors own 97.64% of the company's stock.

Kenvue Stock Performance

KVUE opened at $16.83 on Friday. The company has a market cap of $32.30 billion, a PE ratio of 22.74, a price-to-earnings-growth ratio of 2.31 and a beta of 0.72. The stock has a 50-day moving average of $19.25 and a 200-day moving average of $21.38. Kenvue Inc. has a 52-week low of $15.47 and a 52-week high of $25.17. The company has a debt-to-equity ratio of 0.66, a quick ratio of 0.68 and a current ratio of 0.98.

Kenvue (NYSE:KVUE - Get Free Report) last posted its quarterly earnings data on Thursday, August 7th. The company reported $0.29 earnings per share for the quarter, topping the consensus estimate of $0.28 by $0.01. Kenvue had a return on equity of 20.06% and a net margin of 9.37%.The business had revenue of $3.84 billion during the quarter, compared to analysts' expectations of $3.94 billion. During the same quarter in the previous year, the firm earned $0.32 EPS. The firm's revenue was down 4.0% compared to the same quarter last year. Kenvue has set its FY 2025 guidance at 1.000-1.050 EPS. As a group, equities research analysts forecast that Kenvue Inc. will post 1.14 earnings per share for the current fiscal year.

Kenvue Increases Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Wednesday, August 27th. Investors of record on Wednesday, August 13th were given a dividend of $0.2075 per share. The ex-dividend date of this dividend was Wednesday, August 13th. This represents a $0.83 annualized dividend and a dividend yield of 4.9%. This is a boost from Kenvue's previous quarterly dividend of $0.21. Kenvue's payout ratio is presently 112.16%.

Wall Street Analysts Forecast Growth

A number of brokerages have recently weighed in on KVUE. Evercore ISI lowered their price target on Kenvue from $23.00 to $18.00 and set an "in-line" rating on the stock in a report on Tuesday, September 23rd. Rothschild & Co Redburn upgraded Kenvue from a "neutral" rating to a "buy" rating and lowered their price target for the company from $22.50 to $22.00 in a report on Friday, September 26th. Citigroup lowered their target price on Kenvue from $20.00 to $17.00 and set a "neutral" rating on the stock in a research note on Thursday. Bank of America lowered their target price on Kenvue from $25.00 to $21.00 and set a "buy" rating on the stock in a research note on Wednesday. Finally, The Goldman Sachs Group lowered their target price on Kenvue from $22.00 to $19.00 and set a "neutral" rating on the stock in a research note on Thursday, October 2nd. One research analyst has rated the stock with a Strong Buy rating, five have given a Buy rating, nine have assigned a Hold rating and one has issued a Sell rating to the company's stock. According to data from MarketBeat.com, the company currently has a consensus rating of "Hold" and an average target price of $21.54.

About Kenvue

Kenvue Inc operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee's, ORSLTM, Rhinocort, Calpol, and Zyrtec brands.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.